West Nile virus (WNV) circulation is currently welldocumented in several European countries (Romania, the Czech Republic, France, Spain, Greece and Italy) and, over the past decades, there has been an increase in the geographical distribution and in the numbers of cases in the European Union (Calistri et al., 2010a) . Further, the large increase in the incidence of cases of WNV in North America registered in 2012 makes the possibility of further geographical expansion of the infection in Europe highly likely, under the influence of an expansion of the boundaries of competent vectors. Considering the possibility of chronic and persistent human infections (Murray et al., 2010) and the evidence of serious long-term sequelae in patients with a history of WNV infection (Nolan et al., 2012) , it becomes apparent that WNV infection could have substantial public-health implications and emphasizes the importance of having surveillance systems monitoring the activity of WNV in humans, mosquitoes, birds and other animals.
Phylogenetic analyses have described two major distinct lineages of WNV strains. Lineage 1, further divided into three clades, 1a, 1b and 1c, is responsible for most of the recent outbreaks in Europe, the Mediterranean Basin and North America , whereas a large outbreak in central Macedonia, northern Greece, in the summer of 2010-2011 (Danis et al., 2011) was caused by lineage 2 strains (Chaskopoulou et al., 2011) . Within lineage 1, clade 1a, all WNV strains from western Mediterranean countries constitute a distinct group (WMed) Sotelo et al., 2011) .
The first human cases of WNV infection in Italy were reported in 2008 in Emilia-Romagna (Rossini et al., 2008) . WNV circulation was reported thereafter in other Italian 3These authors contributed equally to this work.
regions (Veneto, Lombardia), with occurrence of several human cases (Rizzo et al., 2009; Calistri et al., 2010b; Capobianchi et al., 2010) . On the basis of phylogenetic analyses, the WNV strains responsible for the Italian outbreaks in 2008-2009 belonged to lineage 1 and constituted a distinct monophyletic group within the WMed cluster (Rossini et al., 2011) . In 2011, 14 human cases of WNV neuroinvasive infections due to lineage 1 strains were registered in Veneto, Friuli Venezia Giulia and Sardinia (Rizzo et al., 2012) . Furthermore, a case of WNV fever caused by a lineage 2 strain was reported in the Marche region (Bagnarelli et al., 2011 reported to have not travelled outside these regions. Viral RNA from serum samples obtained during the acute phase of infection was extracted by using the NucliSens EASYMAG system (bioMérieux) according to the manufacturer's protocol. A fragment of the WNV E gene was amplified by RT-PCR performed with a Transcriptor One-Step RT-PCR kit (Roche) by using primers 59-TGTGGAGGAACAGAG-AGACG-39 and 59-TGAACACCCCTCCAACTGAT-39. The RT-PCR conditions were as follows: 50 u C for 30 min, 94 u C for 7 min, 40 cycles of 94 u C for 10 s, 57 u C for 30 s and 68 u C for 1 min. Amplification products were sequenced bidirectionally. Attempts to isolate viruses in cell culture from biological specimens were not successful. Multiple alignments of the two new sequences of the E region, along with the corresponding sequences from 45 other WNV strains and isolates available in GenBank, were generated by CLUSTAL W software (http://www2.ebi.ac.uk/clustalw).
Phylogenetic analysis of the E sequences ( Fig. 1 ) confirmed that these two strains belong to lineage 1, clade 1a. Both strains fall into the WMed group, but are different from each other and they do not cluster with the monophyletic group formed by strains collected during 2008 and 2009 in Italy (Rossini et al., 2011) (Fig. 1) Interestingly, the sequence of the analysed genome region of RNC37-2011 is not identical (nucleotide distance 1.80 %) to that of AN-1 (GenBank accession no. JN858069), isolated from one infected transplant recipient whose donor was resident in the Veneto region (Costa et al., 2011) , even if they share, presumably, the same geographical origin and the circulation area.
No relevant amino acid changes were observed in the E region compared with the strains of the WMed group.
In conclusion, we provide two new nucleotide sequences of a 566 nt fragment of the E gene from WNV strains obtained in 2011 from patients suffering from WNVrelated neuroinvasive diseases, living in two different regions of Italy (Veneto and Sardinia), and describe their phylogenetic relationship with other WNV strains belonging to the WMed cluster.
The data from the present study, together with other recent data (Bagnarelli et al., 2011; Savini et al., 2012) , show that both WNV lineage 1a and lineage 2 strains were circulating in Italy in the same year (2011). According to Sotelo et al. (2011) , the two strains analysed in the present study belong to the WMed group, and are different from lineage 1 strains circulating in [2008] [2009] in Italy (Rossini et al., 2011) . These data, together with the observation that Italian strains collected in 1998, 2008-2009 and 2011 occupy several branches and lineages in the phylogenetic tree, based on WNV sequences collected over a wide geographical area (Fig. 1) , are consistent with the hypothesis of multiple de novo introductions of WNV strains into Italy.
Interestingly, the two Italian strains analysed in this study show highest sequence similarity to strains collected in Israel starting from 2003. Laboratory contamination as the source of the obtained WNV sequences is highly unlikely, as no Israeli strains had ever been handled in the laboratories where samples were processed. Similarity of these two Italian strains to strains circulating in Israel suggests a common origin, further confirming the model according to which WNV lineage 1a strains originated in North Africa and then spread to western and eastern Mediterranean regions (via the Middle East) by migratory birds (Danis et al., 2011; Zehender et al., 2011) . Further molecular epidemiological studies, combined with geographical and temporal information, are necessary to clarify the spread and evolutionary routes of WNV strains in southern Europe, and will contribute to improving the efficiency of prevention, surveillance and control strategies based on integrated risk-assessment measures and a continuous update of diagnostic techniques.
